PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page
FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

FDA Approves First Treatment for Episodic Cluster Headache that Reduces the Frequency of Attacks

by PEPID Newsroom | Jun 4, 2019 | Alerts

Emgality (gacanezumab-gnlm) solution has been FDA approved for treatment of episodic cluster headache in adults, the first of its kind. Emgality was approved in 2018 to prevent migraines in adults, and now has shown to reduce the frequency of cluster headache attaches...

Recent Posts

  • Dementia in the Emergency Department: Recognizing Delirium, Anticholinergic Burden, and the “Acting Different” Presentation
  • EMS Week in Practice: Strengthening the Prehospital-to-ED Continuum for Better Patient Outcomes
  • Sleep Awareness Week: Why Sleep Health Should Be Part of Every Wellness Visit
  • Autism Acceptance Month: Autism in Clinical Practice—Communication Strategies and Considerations for Better Care
  • Heart Health Month in Practice: What Clinicians Should Watch for in February

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved